TA-TMA as a clinical model for precision complement therapeutics in stem cell transplantation. [PDF]
Jodele S.
europepmc +1 more source
A real-world, multi-center, prospective, observational study for paroxysmal nocturnal haemoglobinuria (PNH) in China: Baseline characteristics, disease burden and treatment patterns. [PDF]
Han B +11 more
europepmc +1 more source
How Severe is Severe Enough? Organ Failure Rather Than Anemia Severity as a Potential Threshold for Complement Inhibition in Pediatric Paroxysmal Cold Hemoglobinuria: A Case Report. [PDF]
Yu C, Rane Z, Nedelcu E, Matsunaga A.
europepmc +1 more source
FACIT-fatigue score and treatment quality assessment for paroxysmal nocturnal hemoglobinuria patients treated with Eculizumab in Türkiye. [PDF]
Narlı Özdemir Z +33 more
europepmc +1 more source
Eculizumab for rapidly progressive glomerulonephritis in children. [PDF]
Cirillo L +11 more
europepmc +1 more source
Eculizumab-Induced Acute Heart Failure Decompensation in a Patient with Clinically Suspected Complement-Mediated Thrombotic Microangiopathy: A Case Report. [PDF]
Huang J +10 more
europepmc +1 more source
Data-augmented machine learning refines the effective-concentration estimate for eculizumab in complement-mediated diseases. [PDF]
Fernández FJ +4 more
europepmc +1 more source
Eculizumab for ATCR-associated <i>de novo</i> thrombotic microangiopathy in a Chinese kidney transplant recipient with type 2 diabetes: a case report. [PDF]
Su S +5 more
europepmc +1 more source
Recurrent Postpartum Atypical Hemolytic Uremic Syndrome Caused by a C3 Pathogenic Variant: A Case Report. [PDF]
Zhu J +5 more
europepmc +1 more source
Case Report: Sequential eculizumab and belimumab in a paediatric patient with lupus nephritis and immune complex-mediated renal microangiopathy. [PDF]
Zhu R +8 more
europepmc +1 more source

